The use of simulation and bootstrap in information-based group sequential studies

Statistics in Medicine

Volumn 17, Issue 1, 1998, Pages 75-87

  Scharfstein, Daniel O ^a   Tsiatis, Anastasios A ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COVARIANCE; MONITORING; PREDICTION; REVIEW; STATISTICAL MODEL; STATISTICAL PARAMETERS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHEMOPREVENTION; CLINICAL TRIALS; COMPUTER SIMULATION; FORECASTING; HUMANS; LONGITUDINAL STUDIES; PNEUMONIA, PNEUMOCYSTIS; RESEARCH DESIGN;

EID: 0032518987     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19980115)17:1<75::AID-SIM731>3.0.CO;2-N     Document Type: Review

References (18)

1. Pocock, S. J. 'Group sequential methods in the design and analysis of clinical trials', Biometrika, 64, 191-199 (1977).
2. O'Brien, P. C. and Fleming, T. R. 'A multiple testing procedure for clinical trials', Biometrics, 35, 549-556 (1979).
3. Lan, G. K. K. and DeMets, D. L. 'Discrete sequential boundaries for clinical trials', Biometrika 70, 659-663 (1983).
4. Wald, A. Sequential Analysis, Wiley, New York, 1947 (reprinted by Dover, New York, 1973).
5. Siegmund, D. Sequential Analysis: Tests and Confidence Intervals, Springer-Verlag, New York, 1985.
6. Lan, G. K. K. and Zucker, D. M. 'Sequential monitoring of clinical trials: the role of information and Brownian motion', Statistics in Medicine, 12, 753-765 (1993).
7. Scharfstein, D. O., Tsiatis, A. A. and Robins, J. M. 'Semiparametric efficiency: implications for the design and analysis of group sequential studies', Jounal of the American Statistical Association, (1997), in press.
8. Wang, S. K. and Tsiatis, A. A. 'Approximately optimal one-parameter boundaries for group sequential trials', Biometrics, 43, 193-199 (1987).
9. Yateman, N. A. and Skene, A. M. 'The use of simulation in the design of two cardiovascular survival studies', Statistics in Medicine, 12, 1365-1372 (1993).
10. Halpern, J. and Brown, B. W. 'Designing clinical trials with arbitrary specification of survival functions and for the logrank or generalized Wilcoxon test', Statistics in Medicine, 8, 177-189 (1987).
11. Halpern, J. and Brown, B. W. 'A computer program for designing clinical trials with arbitrary survival curves and group sequential testing', Statistics in Medicine, 14, 109-122 (1993).
12. Natarajan, R., Turnbull, B. W., Slate, E. H. and Clark, L. C. 'A computer program for sample size and power calculations in the design of multiple-arm and factorial clinical trials with survival time endpoints', Computer Methods and Programs in Biomedicine, 49, 137-147 (1996).
13. Lakatos, E. 'Sample sizes based on the log-rank statistic in complex clinical trials, Biometrics, 44, 229-241 (1988).
14. Lakatos, E. and Lan, G. K. K. 'A comparison of sample size methods for the logrank statistic', Statistics in Medicine, 11, 179-191 (1992).
15. Beran, R. 'Calibrating prediction regions', Journal of the American Statistical Association, 83, 715-723 (1990).
16. Carroll, R. J. and Ruppert, D. 'Prediction and tolerance intervals with transformation and/or weighting', Technometrics, 33, 197-210 (1991).
17. Gould, A. L. 'Interim analyses for monitoring clinical trials that do not materially affect the type I error rate', Statistics in Medicine, 11, 55-66 (1992).
18. Hardy, W. D., Feinberg, J., Finkelstein, D. M., Power, M. E., Weili, H., Kaczka, C., Frame, P. T., Holmes, M. E., Waskin, H., Fass, R. J., Powderly, W. G., Steigbigel, R. T., Zuger, A. and Holzman, R. S. 'A controlled clinical trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis Carinii pneumonia in patients with the Acquired Immunodeficiency Syndrome', New England Journal of Medicine, 327, 1842-1848 (1992).